Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial

Diabetes and Metabolism

Volumn 42, Issue 1, 2016, Pages 47-54

  Gingras, V ^a,b   Rabasa Lhoret, R ^a,b,c,d,f   Messier, V ^a   Ladouceur, M ^d   Legault, L ^e   Haidar, A ^a,f  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Montreal Diabetes Research Center MDRC   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MONTREAL CHILDREN S HOSPITAL   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Artificial pancreas; Carbohydrate counting; Closed loop hormonal delivery systems; Continuous glucose monitoring; Type 1 diabetes

Indexed keywords

GLUCOSE; INSULIN ASPART; RECOMBINANT GLUCAGON; CARBOHYDRATE DIET; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; ARTIFICIAL PANCREAS; CARBOHYDRATE DIET; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HOSPITAL ADMISSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TO CARBOHYDRATE RATIO; INSULIN TREATMENT; LOW CARBOHYDRATE DIET; MALE; METABOLIC PARAMETERS; RANDOMIZED CONTROLLED TRIAL; AGED; ANALYSIS; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; DIABETIC DIET; GLUCOSE BLOOD LEVEL; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PROCEDURES;

ADULT; AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIET, DIABETIC; DIETARY CARBOHYDRATES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREAS, ARTIFICIAL;

EID: 84930599404     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2015.05.001     Document Type: Article

References (28)

1. Imran S.A., Rabasa-Lhoret R., Ross S. Targets for glycaemic control. Can J Diabetes 2013, 37(Suppl. 1):S31-S34.
2. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
3. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003, 290:2159-2167.
4. Cryer P.E. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 2002, 45:937-948.
5. Scavone G., Manto A., Pitocco D., Gagliardi L., Caputo S., Mancini L., et al. Effect of carbohydrate counting and medical nutritional therapy on glycaemic control in Type 1 diabetic subjects: a pilot study. Diabet Med 2010, 27:477-479.
6. Rabasa-Lhoret R., Garon J., Langelier H., Poisson D., Chiasson J.L. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen. Diabetes Care 1999, 22:667-673.
7. Mehta S.N., Quinn N., Volkening L.K., Laffel L.M. Impact of carbohydrate counting on glycaemic control in children with type 1 diabetes. Diabetes Care 2009, 32:1014-1016.
8. Brazeau A.S., Mircescu H., Desjardins K., Leroux C., Strychar I., Ekoe J.M., et al. Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes. Diabetes Res Clin Pract 2013, 99:19-23.
9. Hovorka R. Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol 2011, 7:385-395.
10. Hovorka R., Allen J.M., Elleri D., Chassin L.J., Harris J., Xing D., et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010, 375:743-751.
11. Haidar A., Legault L., Dallaire M., Alkhateeb A., Coriati A., Messier V., et al. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ 2013, 185:297-305.
12. Russell S.J., El-Khatib F.H., Sinha M., Magyar K.L., McKeon K., Goergen L.G., et al. Outpatient glycaemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014, 371:313-325.
13. Leelarathna L., Dellweg S., Mader J.K., Allen J.M., Benesch C., Doll W., et al. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study. Diabetes Care 2014, 37:1931-1937.
14. Nimri R., Muller I., Atlas E., Miller S., Fogel A., Bratina N., et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care 2014, 37:3025-3032.
15. Weinzimer S.A., Steil G.M., Swan K.L., Dziura J., Kurtz N., Tamborlane W.V. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008, 31:934-939.
16. El-Khatib F.H., Russell S.J., Nathan D.M., Sutherlin R.G., Damiano E.R. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010, 2:27ra.
17. Haidar A., Elleri D., Kumareswaran K., Leelarathna L., Allen J.M., Caldwell K., et al. Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetes. Diabetes Care 2013, 36:e173-e174.
18. Haidar A., Duval C., Legault L., Rabasa-Lhoret R. Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation. J Diabetes Sci Technol 2013, 7:1507-1512.
19. Cameron F., Niemeyer G., Wilson D.M., Bequette B.W., Benassi K.S., Clinton P., et al. Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals. Diabetes Technol Ther 2014, 16:728-734.
20. El-Khatib F.H., Russell S.J., Magyar K.L., Sinha M., McKeon K., Nathan D.M., et al. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab 2014, 99:1701-1711.
21. Chase H.P., Doyle F.J., Zisser H., Renard E., Nimri R., Cobelli C., et al. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes. Diabetes Technol Ther 2014, 16:623-632.
22. Haidar A., Farid D., St-Yves A., Messier V., Chen V., Xing D., et al. Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus. Diabetes Metab 2014, 40:211-214.
23. Haidar A., Legault L., Messier V., Mitre T.M., Leroux C., Rabasa-Lhoret R. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional pump therapy in type 1 diabetes: a randomised controlled crossover trial. Lancet Diabetes Endicronol 2014, 3:17-26.
24. Hinshaw L., Dalla Man C., Nandy D.K., Saad A., Bharucha A.E., Levine J.A., et al. Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes 2013, 62:2223-2229.
25. Hovorka R., Elleri D., Thabit H., Allen J.M., Leelarathna L., El-Khairi R., et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care 2014, 37:1204-1211.
26. Russell S.J., El-Khatib F.H., Sinha M., Magyar K.L., McKeon K., Goergen L.G., et al. Outpatient glycaemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014, 371:313-325.
27. Ly T.T., Breton M.D., Keith-Hynes P., De Salvo D., Clinton P., Benassi K., et al. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care 2014, 37:2310-2316.
28. Bell K.J., Barclay A.W., Petocz P., Colagiuri S., Brand-Miller J.C. Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2014, 2:133-140.